Abiopharma

🔍 Bronstein Manuel (Director)

Company: NEW YORK TIMES CO (NYT)

Report Date: 2026-04-22

Detailed Transactions and Holdings:

• Acquired 2,277 shares of Class A Common Stock (Direct)
  Date: 2026-04-22 | Code: A | equity_swap_involved: 0 | shares_owned_after: 20,343.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Consists of a grant of stock-settled restricted stock units under The New York Times Company 2020 Incentive Compensation Plan. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock and vests on the date of the following Annual Meeting of Stockholders. Vested shares will be delivered within 90 days following the cessation of the reporting person's membership on the Board of Directors.